Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Journal Article
Papadopoulos, P., Viennas E., Gkantouna V., Pavlidis C., Bartsakoulia M., Ioannou Z-M., et al. (2014).  Developments in FINDbase worldwide database for clinically relevant genomic variation allele frequencies.. Nucleic Acids Res. 42(Database issue), D1020-6.
Zarogiannis, S., Deligiorgi T., Stefanidis I., Liakopoulos V., Gourgoulianis K., Molyvdas P. Adam, et al. (2009).  Dexamethasone decreases the transmesothelial electrical resistance of the parietal and visceral pleura.. J Physiol Sci. 59(4), 335-9.
Empeslidis, T., Banerjee S., Vardarinos A., & Konstas A. G. P. (2013).  Dexamethasone intravitreal implant for idiopathic retinal vasculitis, aneurysms, and neuroretinitis.. Eur J Ophthalmol. 23(5), 757-60.
Toulis, K. A., Goulis D. G., Msaouel P., & Koutsilieris M. (2012).  Dexamethasone plus somatostatin-analog manipulation as bone metastasis microenvironment-targeting therapy for the treatment of castration-resistant prostate cancer: a meta-analysis of uncontrolled studies.. Anticancer Res. 32(8), 3283-9.
Kastritis, E., Gavriatopoulou M., Kyrtsonis M-C., Roussou M., Hadjiharissi E., Symeonidis A., et al. (2015).  Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study.. Blood. 126(11), 1392-4.
Tsaousi, GG., & Bilotta F. (2016).  Is dexmedetomidine a favorable agent for cerebral hemodynamics?. Indian Journal of Critical Care Medicine. 20(1), 1.
Tsaousi, G. G., & Bilotta F. (2016).  Is dexmedetomidine a favorable agent for cerebral hemodynamics?. Indian J Crit Care Med. 20(1), 1-2.
Tsaousi, G. G., Pourzitaki C., Aloisio S., & Bilotta F. (2018).  Dexmedetomidine as a sedative and analgesic adjuvant in spine surgery: a systematic review and meta-analysis of randomized controlled trials.. Eur J Clin Pharmacol.
Dardalas, I., Stamoula E., Rigopoulos P., Malliou F., Tsaousi G., Aidoni Z., et al. (2019).  Dexmedetomidine effects in different experimental sepsis in vivo models.. Eur J Pharmacol. 856, 172401.
Kolibianakis, E. M., Venetis C. A., & Tarlatzis B. C. (2011).  DHEA administration in poor responders.. Hum Reprod. 26(3), 730-1; author reply 731.
Galli-Tsinopoulou, A., Grammatikopoulou M. G., Stylianou C., Emmanouilidou E., & Kokka P. (2010).  Diabese youngsters have 3.7 more chances in developing metabolic syndrome compared with the obese.. J Endocrinol Invest. 33(8), 549-53.
Giouleme, O., Diamantidis M. D., & Katsaros M. G. (2011).  Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms.. World J Gastroenterol. 17(4), 444-8.
Paschou, S. A., Anagnostis P., Vryonidou A., & Goulis D. G. (2018).  Diabetes and Atherosclerosis: Old Players in a New Field, Osteoporosis.. Curr Vasc Pharmacol. 16(6), 524-527.
Athyros, V. G., Doumas M., Imprialos K. P., Stavropoulos K., Georgianou E., Katsimardou A., et al. (2018).  Diabetes and lipid metabolism.. Hormones (Athens). 17(1), 61-67.
Papavramidou, N., & Christopoulou-Aletra H. (2007).  Diabetes and the 'Natural Faculties' in the Galenic treatises.. Hormones (Athens). 6(2), 157-9.
Paschou, S. A., Anagnostis P., Pavlou D. I., Vryonidou A., Goulis D. G., & Lambrinoudaki I. (2019).  Diabetes in Menopause: Risks and Management.. Curr Vasc Pharmacol. 17(6), 556-563.
Polyzos, S. A., & Mantzoros C. S. (2021).  Diabetes mellitus: 100 years since the discovery of insulin.. Metabolism. 118, 154737.
Hatzitolios, A. I., Didangelos T. P., Zantidis A. T., Tziomalos K., Giannakoulas G. A., & Karamitsos D. T. (2009).  Diabetes mellitus and cerebrovascular disease: which are the actual data?. J Diabetes Complications. 23(4), 283-96.
Anastasiadis, K., & Moschos G. (2007).  Diabetes mellitus and coronary revascularization procedures.. Int J Cardiol. 119(1), 10-4.
Moschopoulou, M., Ampatzidou F. Ch, Loutradis C., Boutou A., Koutsogiannidis C-P., Drosos G. E., et al. (2016).  Diabetes mellitus does not affect the incidence of acute kidney injury after cardiac surgery; a nested case-control study.. J Nephrol. 29(6), 835-845.
Loutradis, C., Skodra A., Georgianos P., Tolika P., Alexandrou D., Avdelidou A., et al. (2016).  Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney disease: A nested case-control study.. World J Nephrol. 5(4), 358-66.
Ioannidis, I. (2014).  Diabetes treatment in patients with renal disease: Is the landscape clear enough?. World J Diabetes. 5(5), 651-8.
Sarafidis, P. A., & Lasaridis A. N. (2010).  Diabetic nephropathy: Endothelin antagonism for diabetic nephropathy.. Nat Rev Nephrol. 6(8), 447-9.
Baltzis, D., Roustit M., Grammatikopoulou M. G., Katsaboukas D., Athanasiou V., Iakovou I., et al. (2016).  Diabetic Peripheral Neuropathy as a Predictor of Asymptomatic Myocardial Ischemia in Type 2 Diabetes Mellitus: A Cross-Sectional Study.. Adv Ther. 33(10), 1840-1847.
Praidou, A., Androudi S., Brazitikos P., Karakiulakis G., Papakonstantinou E., Tsinopoulos I., et al. (2014).  Diabetic retinopathy treated with laser photocoagulation and the indirect effect on glycaemic control.. J Diabetes Res. 2014, 158251.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές